Charmacy Pharmaceutical Co., Ltd. (2289.HK)

HKD 9.0

(0.0%)

Net Income Summary of Charmacy Pharmaceutical Co., Ltd.

  • Charmacy Pharmaceutical Co., Ltd.'s latest annual net income in 2023 was 51.34 Million CNY , down -43.25% from previous year.
  • Charmacy Pharmaceutical Co., Ltd.'s latest quarterly net income in 2024 Q2 was 26.74 Million CNY , up 7.02% from previous quarter.
  • Charmacy Pharmaceutical Co., Ltd. reported an annual net income of 90.47 Million CNY in 2022, up 290.76% from previous year.
  • Charmacy Pharmaceutical Co., Ltd. reported an annual net income of 23.15 Million CNY in 2021, down -42.91% from previous year.
  • Charmacy Pharmaceutical Co., Ltd. reported a quarterly net income of 26.35 Million CNY for 2023 Q2, down -62.26% from previous quarter.
  • Charmacy Pharmaceutical Co., Ltd. reported a quarterly net income of 51.34 Million CNY for 2023 FY, down -43.25% from previous quarter.

Annual Net Income Chart of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Historical Annual Net Income of Charmacy Pharmaceutical Co., Ltd. (2023 - 2013)

Year Net Income Net Income Growth
2023 51.34 Million CNY -43.25%
2022 90.47 Million CNY 290.76%
2021 23.15 Million CNY -42.91%
2020 40.55 Million CNY 1.0%
2019 40.15 Million CNY -11.62%
2018 45.43 Million CNY 1.5%
2017 44.75 Million CNY -24.58%
2016 59.34 Million CNY 125.15%
2015 26.35 Million CNY -27.67%
2014 36.44 Million CNY 64.03%
2013 22.21 Million CNY 0.0%

Peer Net Income Comparison of Charmacy Pharmaceutical Co., Ltd.

Name Net Income Net Income Difference
Wanjia Group Holdings Limited -39.97 Million HKD 228.436%
China Health Group Limited -40.18 Million HKD 227.765%
Tai United Holdings Limited -1.16 Billion HKD 104.396%